These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8182397)

  • 1. Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia.
    Feussner G; Feussner V; Ziegler R
    J Intern Med; 1994 May; 235(5):425-30. PubMed ID: 8182397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.
    Feussner G; Wagner A; Ziegler R
    Hum Genet; 1993 Sep; 92(2):122-6. PubMed ID: 8370576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.
    Breslow JL; Zannis VI; SanGiacomo TR; Third JL; Tracy T; Glueck CJ
    J Lipid Res; 1982 Nov; 23(8):1224-35. PubMed ID: 7175379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J
    Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo E variants in patients with type III hyperlipoproteinemia.
    Civeira F; Pocoví M; Cenarro A; Casao E; Vilella E; Joven J; González J; Garcia-Otín AL; Ordovás JM
    Atherosclerosis; 1996 Dec; 127(2):273-82. PubMed ID: 9125318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
    Roeseler E; Julius U; Heigl F; Spitthoever R; Heutling D; Breitenberger P; Leebmann J; Lehmacher W; Kamstrup PR; Nordestgaard BG; Maerz W; Noureen A; Schmidt K; Kronenberg F; Heibges A; Klingel R;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2019-27. PubMed ID: 27417585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
    Sandholzer C; Feussner G; Brunzell J; Utermann G
    J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids, lipoproteins and apolipoprotein E phenotypes in relatives of patients with type III hyperlipoproteinaemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Eur J Clin Invest; 1984 Jun; 14(3):219-26. PubMed ID: 6432551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
    J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in normoglycaemic relatives of type 2 diabetic patients.
    Stewart MW; Webster JM; Humphriss D; Berrish T; Walker M; Laker MF
    Atherosclerosis; 1996 Jul; 124(1):119-24. PubMed ID: 8800499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patient.
    Havekes LM; Gevers Leuven JA; van Corven E; de Wit E; Emeis JJ
    Eur J Clin Invest; 1984 Feb; 14(1):7-11. PubMed ID: 6321197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
    Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
    Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype.
    Feussner G; Ziegler R
    J Intern Med; 1991 Aug; 230(2):183-6. PubMed ID: 1865171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of serum lipoprotein(a) and the relation to phenotypes and genotypes of apolipoprotein(a) in type 2 diabetic patients with retinopathy.
    Suehiro M; Ohkubo K; Kato H; Kido Y; Anzai K; Oshima K; Ono J
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):319-24. PubMed ID: 12397529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.